期刊文献+

HLA class Ⅰ expression in primary hepatocellular carcinoma 被引量:33

HLA class Ⅰ expression in primary hepatocellular carcinoma
下载PDF
导出
摘要 AIM:To investigate whetherCTL vaccine therapy is suitable for primary hepatocellular carcinoma(HCC)from the viewpoint of HLA classIantigens expression.METHODS:The immunocytochemistry,image analysis,flow cytometry,and labeled streptavidin bioti(LSAB)method of immunohistochemistry were applied respectively to study 4HCCcell lines(e.g.Alexander,HepG2,SMMC-7721,andQGY-7703)cultured in vitro and 6frozen tissue specimens of HCC.RESULTS:The positive control cell line Raji had very strong positive staining,Most mitotic and nonmitotic cells of the 4HCCcell lines had various intensity of HLAclassⅠantigens expression.The negative control cell K562 and the control slides of all the cell lines had no positive staining,In the 6HCCspecimens immunohistochemically studied,histological normal hepatocytes had no or very weak positive staining and the liver sinus had very strong positive staining.Most HCCcells in the sections from the 6HCCspecimens had strong positive HLAclassⅠantigens staining.The positive staining was located in the cytoplasm,the perinuclear area,and at the cell membrane of the liver cancer cells.Flow cytometry also revealed that Raji and those 4HCCcell lines had strong HLAclassⅠantigens expression.which was confirmed quantitatively by the image analysis.It showed that the objective grayscale values of Raji and those 4HCCcell lines were significantly different from that of K562(Raji114.04±10.94,Alexander165.97±5.35,HepG2167.02±12.60,QGY-7703161.46±7.13,SMMC-7721 165.93±5.21,K562244.89±4.60,P<0.01).Significant differences were also found ebtween Raji and the 4HCCcell lines.CONCLUSION:HCC cells express HLA classI antigens strongly,Fromthis point of view.the active specific immunotherapy of CTL vaccine is suitable and practicable for HCC. AIM:TO investigate whether CTL vaccine therapy is suitable for primary hepatocellular carcinoma(HCC) from the viewpoint of HLA class Ⅰ antigens expression. METHODS:The immunocytochemistry,image analysis, flow cytometry,and labeled streptavidin biotin(LSAB) method of immunohistochemistry were applied respectively to study 4 HCC call lines(e.g.Alexander, HepG2,SMMC-7721,and QGY-7703)cultured in vitro and 6 frozen tissue specimens of HCC. RESULTS:The positive control cell line Raji had very strong positive staining.Most mitotic and nonmitotic cells of the 4 HCC cell lines had various intensity of HLA class Ⅰ antigens expression.The negative control cell K562 and the control slides of all the cell lines had no positive staining.In the 6 HCC specimens immunohistochemically studied,histological normal hepatocytes had no or very weak positive staining and the liver sinus had very strong positive staining.Most HCC cells in the sections from the 6 HCC specimens had strong positive HLA class Ⅰ antigens staining.The positive staining was located in the cytoplasm,the perinuclear area,and at the call membrane of the liver cancer calls.Flow cytemetry also revealed that Raji and those 4 HCC cell lines had strong HLA class Ⅰ antigens expression,which was confirmed quantitatively by the image analysis.It showed that the objective grayscale values of Raji and those 4 HCC cell lines were significanUy different from that of K562(Raji 114.04± 10.94,Alexander 165.97±5.35,HepG2 167.02±12.60, QGY-7703 161.46±7.13,SMMC-7721 165.93±5.21, KS62 244.89±4.60,P<0.01).Significant differences were also found between Raji and the 4 HCC call lines. CONCLUSION:HCC cells express HLA class Ⅰ antigens strongly.From this point of view,the active specific immunetherapy of CTL vaccine is suitable and practicable for HCC.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2002年第4期654-657,共4页 世界胃肠病学杂志(英文版)
基金 the National Natural Science Foundation of China,No.30070855
  • 相关文献

参考文献10

  • 1Paroli M,Carloni G,Franco A,De Petrillo G,Alfani E,Perrone A,Barnaba V.Human hepatoma cells expressing MHC antigens display accessory cell function,dependence on LFA-1/ICAM-1 interaction[].Immunology.1994
  • 2Ruiz-Cabello F,Garrido F.HLAand cancer:Fromresearch to clinical impact[].Immunology Today.1998
  • 3Sung CH,Hu CP,Hsu HC,Ng AK,Chou CK,Ting LP,Su TS,Han SH,Chang CM.Expression of class Ⅰ and class Ⅱ major histocompatibility antigens on human hepatocellular carcinoma[].The Journal of Clinical Investigation.1989
  • 4Wadee A A,Paterson A,Coplan KA,Reddy SG.HLA expression in hepatocellular carcinoma lines[].Clinical and Experimental Immunology.1994
  • 5Alexander,JJ,Bey,EM,Geddes,EW,Lecatsas,G.Establishment of a continuously growing cell line from primary carcinoma of the liver[].South African Medical Journal.1976
  • 6Aden,DP,Fogel,A,Plotkin,S,Damjanov,I,Knowles,BB.Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line[].Nature.1979
  • 7Jr,Vollmer,CM,Eilber,FC,Butterfield,LH,Ribas,A,Dissette,VB,Koh,A,Montejo,LD,Lee,MC,Andrews,KJ,McBride,WH,Glaspy,JA,Economou,JS.Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma[].Cancer Research.1999
  • 8Butterfield,LH,Koh,A,Meng,W,Vollmer,CM,Ribas,A,Dissette,V,Lee,E,Glaspy,JA,McBride,WH,Economou,JS.Generation of Human T-cell Responses to an HLA-A2.1-restricted peptide epitope derived from alpha-Fetoprotein[].Cancer Research.1999
  • 9Butterfield L,Meng W,Koh A,et al.T cell responses to HLA-A* 0201-restricted peptides derived from human alpha-fetoprotein[].J Immunol.2001
  • 10Paterson AC,Sciot R,Kew MC,Callea F,Dusheiko GM,Desmet VJ.HLA expression in human hepatocellular carcinoma[].British Journal of Cancer.1988

同被引文献321

引证文献33

二级引证文献244

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部